Angiotensin-Converting Enzyme Inhibitor (SQ 20881) in the Diagnosis of Renovascular Hypertension

Abstract

SQ 20881, an angiotensin-converting enzyme inhibitor, was given to 12 patients with renovascular hypertension and to 1 patient with unilateral pa renchymatous renal disease in order to evaluate the role of renin-angiotensin systems in their hypertension. Plasma renin activity (PRA) and aldosterone were assayed in systemic blood before and after the injection of SQ 20881. In 5 patients PRA was also measured separately in each renal vein. Blood pressure decreased, PRA increased, and aldosterone level decreased in the 12 renin- dependant patients. When PRA was sampled separately from each renal vein, the increase was larger on the side of the affected kidney. Four patients with a positive test underwent corrective surgery, and in all blood pressure became normal. SQ 20881 is a useful agent in evaluating the contribution of renin in patients with hypertension.

Get full access to this article

View all access options for this article.

References

Collier, J.G. , Robinson, B.F. , Vane, J.R. : Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P.9a or SQ 20881) which inhibits converting enzyme. Lancet, 1: 72, 1973.

Gavras, H. , Brunner, H.R. , Laragh, J.H. : An angiotensin converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N. Engl. J. Med., 291: 817, 1974.

Rosenthal, T. , Adar, R. , Stern, N. , et al.: The use of SQ 20881 for lateralising renal venous renin activity. Isr. J. Med. Sci., in press.

Buhler, F.R. , Sealey, J.E. , Laragh, J.H. : Radioimmunoassay of plasma aldosterone, in Hypertension Manual . Edited by J. H. Laragh. New York, Yorke Medical Books, 1974 , p. 655.

Case, D.B. , Wallace, J.M. , Keim, H.J. , et al.: Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N. Engl. J. Med. 296: 641, 1977.

Case, D.B. , Wallace, J.M. , Keim, H.J. , et al.: Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin. Am. J. Med. 61: 790, 1976.

Miller, E.D. , Samuels, A.I. , Hober, E. , et al.: Inhibition of angiotensin conversion and prevention of renal hypertension. Am. J. Physiol., 228: 448, 1975.

Sancho, J. , Re, R. , Burton, J. , et al.: The role of renin-angiotensinaldosterone system in cardiovascular hemostasis in normal human subjects. Circulation, 53: 400, 1976.

Williams, G.H. , Hollenberg, N.K. : Accentuated vascular and endocrine response to SQ 20881 in hypertension. N. Engl. J. Med., 297: 184, 1977.

10.

Williams, G.H. : Angiotensin-dependant hypertension—Potential pitfalls in definition. N. Engl. J. Med., 296: 684, 1977 .

11.

Duhme, D.W. , Sancho, J. , Athanasoulis, C. , et al.: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20881. Lancet , 1: 408, 1974.

12.

Gavras, H.R. , Ribeiro, A.B. , Gavras, I. , et al.: Reciprocal relation between renin dependancy and sodium dependancy in essential hypertension. N. Engl. J. Med., 295: 1278, 1976.